These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1346965)

  • 1. The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.
    Kretschmer BD; Zadow B; Volz TL; Volz L; Schmidt WJ
    J Neural Transm Gen Sect; 1992; 87(1):23-35. PubMed ID: 1346965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks.
    Bischoff C; Tiedtke PI
    Eur J Pharmacol; 1992 Mar; 213(2):269-73. PubMed ID: 1355738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.
    Wlaź P
    Brain Res Bull; 1998 Aug; 46(6):535-40. PubMed ID: 9744291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.
    Hauber W; Andersen R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):486-90. PubMed ID: 8114947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
    Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
    Bubser M; Keseberg U; Notz PK; Schmidt WJ
    Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
    Tzschentke TM; Schmidt WJ
    Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors.
    Hauber W; Münkle M
    Neurosci Lett; 1995 Aug; 196(3):205-8. PubMed ID: 7501284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
    Maj J; Skuza G; Rogóz Z
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):53-62. PubMed ID: 8105798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
    Dall'olio R; Rimondini R; Gandolfi O
    Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
    Melo LL; Santos P; Medeiros P; Mello RO; Ferrari EA; Brandão ML; Maisonnette SS; Francisco A; Coimbra NC
    Brain Res; 2010 Aug; 1349():41-7. PubMed ID: 20558148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.
    Poleszak E; Wlaź P; Wróbel A; Fidecka S; Nowak G
    Pharmacol Rep; 2008; 60(5):655-63. PubMed ID: 19066411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function.
    Dall'Olio R; Gaggi R; Bonfante V; Gandolfi O
    Behav Pharmacol; 1999 Feb; 10(1):63-71. PubMed ID: 10780303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.